Merck

Almost three years after whiffing in a confirmatory study, Merck touts new data for Keytruda in HCC
Endpoints
Wed, 01/19/22 - 10:59 am
Merck
Keytruda
liver cancer
HCC
The top 10 biopharma M&A deals in 2021
Fierce Pharma
Tue, 01/18/22 - 10:53 am
M&A
CSL
Vifor
Jazz Pharmaeuticals
GW Pharma
Novo Nordisk
Dicerna
Horizon Therapeutics
Viela Bio
Perrigo
HRA Pharma
Sanofi
Kadmon
Merck
Acceleron
Pfizer
Arena Pharmaceuticals
Translate Bio
Trillium Therapeutics
Amgen
Five Prime Therapeutics
Biotech investors pray for a takeover miracle
EP Vantage
Fri, 01/14/22 - 11:09 am
M&A
biotech
Amylyx Pharmaceuticals
Arena Pharmaceuticals
AstraZeneca
Aurinia Pharmaceuticals
Biogen
Biohaven
Bristol Myers Squibb
Eli Lilly
GSK
Merck
Novartis
Novo Nordisk
Pfizer
Sanofi
Chasing Roche, Merck unveils adjuvant lung cancer data for Keytruda
Pharmaforum
Tue, 01/11/22 - 11:28 am
Merck
Roche
Keytruda
clinical trials
non-small cell lung cancer
Tecentriq
Idorsia scores FDA go-ahead for insomnia drug Quviviq to rival Merck’s Belsomra, Eisai’s Dayvigo
Fierce Pharma
Mon, 01/10/22 - 11:37 pm
Idorsia
Quviviq
insomnia
FDA
Merck
Belsomra
Atea sticks it out with failed COVID-19 antiviral but also raids Merck's store room for hepatitis C drug
Fierce Biotech
Fri, 01/7/22 - 10:47 am
Atea Pharmaceuticals
antivirals
COVID-19
Merck
bemnifosbuvir.
Merck, putting $150M on the table, doubles down on pledge tackle maternal mortality and health inequities
Fierce Pharma
Fri, 01/7/22 - 10:35 am
Merck
maternal health
Women's Health
Merck KGaA buys manufacturer of key component in mRNA medicines
BioPharma Dive
Thu, 01/6/22 - 12:37 pm
Merck
KGaA
MRNA
M&A
Exelead
Dr Reddy's to launch generic COVID-19 Merck drug at about 50 cents a pill
Reuters
Tue, 01/4/22 - 10:46 pm
Dr Reddy's
Merck
generics
COVID-19
molnupiravir
Biopharma developments over the Christmas period
EP Vantage
Mon, 01/3/22 - 10:26 am
Alnylam Pharmaceuticals
Bio-Thera Solutions
BioArctic
Biogen
BridgeBio Pharma
Daiichi Sankyo
Eisai
JNJ
Madrigal Pharmaceuticals
Merck
Sutro BioPharma
Tasly Pharmaceutical Group
France Rejects Merck's COVID-19 Pill: How Bad Is the News?
Motley Fool
Sun, 01/2/22 - 11:39 pm
Merck
COVID-19
molnupiravir
France
FDA authorizes Merck’s Covid-19 pill, but stresses its use should be limited
Stat
Thu, 12/23/21 - 12:03 pm
FDA
Merck
molnupiravir
COVID-19
Efficacy of Pfizer's Covid pill holds up in final analysis, reducing risk of hospitalization or death by almost 90%
Endpoints
Tue, 12/14/21 - 11:21 am
Pfizer
Paxlovid
clinical trials
COVID-19
antivirals
Merck
Merck’s Covid Pill Might Pose Risks for Pregnant Women
NY Times, NY
Mon, 12/13/21 - 11:52 pm
Merck
COVID-19
molnupiravir
pregnancy
DNA
Bellus soars on positive mid-stage readout for its Merck cough rival, despite a failure in atopic dermatitis
Endpoints
Mon, 12/13/21 - 11:06 am
Bellus Health
chronic cough
Merck
BLU-5937
gefapixant
Why an FDA Panel Had Concerns About Merck's COVID-19 Pill
Motley Fool
Sat, 12/11/21 - 09:26 pm
Merck
COVID-19
FDA
molnupiravir
Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multipronged R&D strategy
Fierce Biotech
Tue, 12/7/21 - 10:43 am
Merck
HIV
clinical trials
MK-8507
Immuno-oncology spotlight falls on cervical cancer
EP Vantage
Tue, 12/7/21 - 10:39 am
immuno-oncology
cervical cancer
Opdivo
Keytruda
Bristol Myers Squibb
Merck
Keytruda wins eighth FDA approval of 2021, moving into adjuvant and pediatric melanoma settings
Endpoints
Mon, 12/6/21 - 10:57 am
Merck
Keytruda
melanoma
adolescents
How Pfizer developed a COVID pill in record time
NPR
Fri, 12/3/21 - 10:55 am
Pfizer
Merck
COVID-19
antivirals
Paxlovid
drug development

Pages